Gene · 3292
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stem cells and exosomes: as biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS). | Front Endocrinol (Lausanne) | 2023 | 37964963 | PubTator, text mining | PubMed |
| Local production of 17β-oestradiol in the endometrium during the implantation window: a pilot study. | Reprod Fertil | 2023 | 37962510 | PubTator, text mining | PubMed |
| Natural Products-Pyrazine Hybrids: A Review of Developments in Medicinal Chemistry. | Molecules | 2023 | 37959859 | PubTator, text mining | PubMed |
| Potential Significance of Serum Autoantibodies to Endometrial Antigens, α-Enolase and Hormones in Non-Invasive Diagnosis and Pathogenesis of Endometriosis. | Int J Mol Sci | 2023 | 37958566 | PubTator, text mining | PubMed |
| 17β-hydroxysteroid dehydrogenase type 1 improves survival in serous epithelial ovarian tumors. | Endocr Connect | 2023 | 37924640 | PubTator, text mining | PubMed |
| Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer. | Pharmaceuticals (Basel) | 2023 | 37895937 | PubTator, text mining | PubMed |
| Synthesis of Metabolites and Metabolite-like Compounds Using Biocatalytic Systems. | Metabolites | 2023 | 37887422 | PubTator, text mining | PubMed |
| Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer. | BMC Med Genomics | 2023 | 37880682 | PubTator, text mining | PubMed |
| Effects of natural products on polycystic ovary syndrome: From traditional medicine to modern drug discovery. | Heliyon | 2023 | 37867816 | PubTator, text mining | PubMed |
| The significance of immune microenvironment in patients with endometriosis. | Rom J Morphol Embryol | 2023 | 37867352 | PubTator, text mining | PubMed |
| Polycystic ovary syndrome: pathophysiology and therapeutic opportunities. | BMJ Med | 2023 | 37859784 | PubTator, text mining | PubMed |
| Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia. | Front Immunol | 2023 | 37854606 | PubTator, text mining | PubMed |
| The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives. | Front Endocrinol (Lausanne) | 2023 | 37850096 | PubTator, text mining | PubMed |
| Assessment of steroid enzymes action in children and adolescents with obesity. | Steroids | 2023 | 37806604 | PubTator, text mining | PubMed |
| Salivary androgens in adolescence and their value as a marker of puberty: results from the SCAMP cohort. | Endocr Connect | 2023 | 37800674 | PubTator, text mining | PubMed |
The Comparative Study of the Administration of the Combination Preparation of Isoflavones and Hyaluronic Acid in Menopausal Women for the Treatment of the Symptoms of Menopause, Urogenital Atrophy and Oteoporosis in Relation to Existing Hormone Replacement Therapies. | Mater Sociomed | 2023 | 37795159 | PubTator, text mining | PubMed |
| Data Mining of Microarray Datasets in Translational Neuroscience. | Brain Sci | 2023 | 37759919 | PubTator, text mining | PubMed |
| Bisphenol analogues inhibit human and rat 17β-hydroxysteroid dehydrogenase 1: 3D-quantitative structure-activity relationship (3D-QSAR) and in silico docking analysis. | Food Chem Toxicol | 2023 | 37758047 | PubTator, text mining | PubMed |
| Advances in genetic variation in metabolism-related fatty liver disease. | Front Genet | 2023 | 37753315 | PubTator, text mining | PubMed |
| CRISPR/Cas9-mediated activation of NR5A1 steers female human embryonic stem cell-derived bipotential gonadal-like cells towards a steroidogenic cell fate. | J Ovarian Res | 2023 | 37726790 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3292/papers?page=8